메뉴 건너뛰기




Volumn 62, Issue 12, 2013, Pages 1876-1885

Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: A systematic review and meta-analysis

Author keywords

Adiponectin; Dyslipidemia; Fibrates; Meta analysis; Randomized controlled trial; Statins

Indexed keywords

ADIPONECTIN; ATORVASTATIN; BEZAFIBRATE; CHOLESTEROL; CIPROFIBRATE; CLOFIBRATE; CLOFIBRIC ACID; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

EID: 84888007780     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.08.017     Document Type: Article
Times cited : (17)

References (96)
  • 2
    • 4344607526 scopus 로고    scopus 로고
    • Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin
    • U. Meier, and A.M. Gressner Endocrine regulation of energy metabolism: review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin Clin Chem 50 2004 1511 1525
    • (2004) Clin Chem , vol.50 , pp. 1511-1525
    • Meier, U.1    Gressner, A.M.2
  • 3
    • 0028787490 scopus 로고
    • A novel serum protein similar to C1q, produced exclusively in adipocytes
    • P.E. Scherer, S. Williams, and M. Fogliano A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
    • (1995) J Biol Chem , vol.270 , pp. 26746-26749
    • Scherer, P.E.1    Williams, S.2    Fogliano, M.3
  • 4
    • 0036750241 scopus 로고    scopus 로고
    • Adiponectin - Its role in metabolism and beyond
    • N. Stefan, and M. Stumvoll Adiponectin - its role in metabolism and beyond Horm Metab Res 34 2002 469 474
    • (2002) Horm Metab Res , vol.34 , pp. 469-474
    • Stefan, N.1    Stumvoll, M.2
  • 5
    • 0036511213 scopus 로고    scopus 로고
    • ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism
    • A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol Metab 13 2002 84 89
    • (2002) Trends Endocrinol Metab , vol.13 , pp. 84-89
    • Berg, A.H.1    Combs, T.P.2    Scherer, P.E.3
  • 6
    • 81155137747 scopus 로고    scopus 로고
    • Effects of leptin and adiponectin on pancreatic β-cell function
    • Y.H. Lee, F. Magkos, and C.S. Mantzoros Effects of leptin and adiponectin on pancreatic β-cell function Metabolism 60 2011 1664 1672
    • (2011) Metabolism , vol.60 , pp. 1664-1672
    • Lee, Y.H.1    Magkos, F.2    Mantzoros, C.S.3
  • 7
    • 80054974212 scopus 로고    scopus 로고
    • Plasma adiponectin - An independent indicator of liver fat accumulation
    • P. Pisto, O. Ukkola, and M. Santaniemi Plasma adiponectin - an independent indicator of liver fat accumulation Metabolism 60 2011 1515 1520
    • (2011) Metabolism , vol.60 , pp. 1515-1520
    • Pisto, P.1    Ukkola, O.2    Santaniemi, M.3
  • 8
    • 79951810722 scopus 로고    scopus 로고
    • Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis
    • S.A. Polyzos, K.A. Toulis, D.G. Goulis, C. Zavos, and J. Kountouras Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis Metabolism 60 2011 313 326
    • (2011) Metabolism , vol.60 , pp. 313-326
    • Polyzos, S.A.1    Toulis, K.A.2    Goulis, D.G.3    Zavos, C.4    Kountouras, J.5
  • 9
    • 33750515920 scopus 로고    scopus 로고
    • Role of adipokines in the control of energy metabolism: Focus on adiponectin
    • M. Lafontan, and N. Viguerie Role of adipokines in the control of energy metabolism: focus on adiponectin Curr Opin Pharmacol 6 2006 580 585
    • (2006) Curr Opin Pharmacol , vol.6 , pp. 580-585
    • Lafontan, M.1    Viguerie, N.2
  • 10
    • 84870401115 scopus 로고    scopus 로고
    • Protective role of adiponectin in cardiovascular disease
    • R. Shibata, T. Murohara, and N. Ouchi Protective role of adiponectin in cardiovascular disease Curr Med Chem 19 2012 5459 5466
    • (2012) Curr Med Chem , vol.19 , pp. 5459-5466
    • Shibata, R.1    Murohara, T.2    Ouchi, N.3
  • 11
    • 84858199982 scopus 로고    scopus 로고
    • Adiponectin and cardiovascular disease: Mechanisms and new therapeutic approaches
    • G. Siasos, D. Tousoulis, and C. Kollia Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches Curr Med Chem 19 2012 1193 1209
    • (2012) Curr Med Chem , vol.19 , pp. 1193-1209
    • Siasos, G.1    Tousoulis, D.2    Kollia, C.3
  • 12
    • 81855177709 scopus 로고    scopus 로고
    • Adiponectin and cardiovascular health: An update
    • X. Hui, K.S. Lam, and P.M. Vanhoutte Adiponectin and cardiovascular health: an update Br J Pharmacol 165 2012 574 590
    • (2012) Br J Pharmacol , vol.165 , pp. 574-590
    • Hui, X.1    Lam, K.S.2    Vanhoutte, P.M.3
  • 13
    • 84869487793 scopus 로고    scopus 로고
    • Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease
    • Q. Li, Y. Lu, and L. Sun Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease Metabolism 61 2012 1803 1808
    • (2012) Metabolism , vol.61 , pp. 1803-1808
    • Li, Q.1    Lu, Y.2    Sun, L.3
  • 14
    • 78751646231 scopus 로고    scopus 로고
    • Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure
    • D. Giannessi, C. Caselli, and S. Del Ry Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure Metabolism 60 2011 227 233
    • (2011) Metabolism , vol.60 , pp. 227-233
    • Giannessi, D.1    Caselli, C.2    Del Ry, S.3
  • 15
    • 84866002800 scopus 로고    scopus 로고
    • Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism
    • Q. Liu, B. Yuan, and K.A. Lo Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism Proc Natl Acad Sci U S A 109 2012 14568 14573
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 14568-14573
    • Liu, Q.1    Yuan, B.2    Lo, K.A.3
  • 16
    • 34047265043 scopus 로고    scopus 로고
    • Role of adiponectin in the regulation of carbohydrate and lipid metabolism
    • J. Karbowska, and Z. Kochan Role of adiponectin in the regulation of carbohydrate and lipid metabolism J Physiol Pharmacol 57 2006 S103 S113
    • (2006) J Physiol Pharmacol , vol.57
    • Karbowska, J.1    Kochan, Z.2
  • 17
    • 84866107607 scopus 로고    scopus 로고
    • Insulin-sensitizing properties of adiponectin
    • J.M. Tishinsky, L.E. Robinson, and D.J. Dyck Insulin-sensitizing properties of adiponectin Biochimie 94 2012 2131 2136
    • (2012) Biochimie , vol.94 , pp. 2131-2136
    • Tishinsky, J.M.1    Robinson, L.E.2    Dyck, D.J.3
  • 19
    • 34548406102 scopus 로고    scopus 로고
    • Adiponectin, obesity and atherosclerosis
    • C.J. Behre Adiponectin, obesity and atherosclerosis Scand J Clin Lab Invest 67 2007 449 458
    • (2007) Scand J Clin Lab Invest , vol.67 , pp. 449-458
    • Behre, C.J.1
  • 20
    • 27544513825 scopus 로고    scopus 로고
    • Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance
    • M. Haluzik Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance Curr Opin Investig Drugs 6 2005 988 993
    • (2005) Curr Opin Investig Drugs , vol.6 , pp. 988-993
    • Haluzik, M.1
  • 21
    • 84870735957 scopus 로고    scopus 로고
    • Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose
    • X. Li, M.R. Li, and Z.X. Guo Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose Chin Med J 125 2012 4209 4213
    • (2012) Chin Med J , vol.125 , pp. 4209-4213
    • Li, X.1    Li, M.R.2    Guo, Z.X.3
  • 22
    • 84866054662 scopus 로고    scopus 로고
    • Adiponectin: Anti-inflammatory and cardioprotective effects
    • M.T. Villarreal-Molina, and B. Antuna-Puente Adiponectin: anti-inflammatory and cardioprotective effects Biochimie 94 2012 2143 2149
    • (2012) Biochimie , vol.94 , pp. 2143-2149
    • Villarreal-Molina, M.T.1    Antuna-Puente, B.2
  • 23
    • 33947627537 scopus 로고    scopus 로고
    • Adiponectin as an anti-inflammatory factor
    • N. Ouchi, and K. Walsh Adiponectin as an anti-inflammatory factor Clin Chim Acta 380 2007 24 30
    • (2007) Clin Chim Acta , vol.380 , pp. 24-30
    • Ouchi, N.1    Walsh, K.2
  • 25
    • 0034096988 scopus 로고    scopus 로고
    • Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
    • K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1595-1599
    • Hotta, K.1    Funahashi, T.2    Arita, Y.3
  • 26
    • 11144346107 scopus 로고    scopus 로고
    • Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesionmolecules in subjects with metabolic syndrome
    • U. Salmenniemi, E. Ruotsalainen, and J. Pihlajamaki Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesionmolecules in subjects with metabolic syndrome Circulation 110 2004 3842 3848
    • (2004) Circulation , vol.110 , pp. 3842-3848
    • Salmenniemi, U.1    Ruotsalainen, E.2    Pihlajamaki, J.3
  • 27
    • 48649107955 scopus 로고    scopus 로고
    • Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in non-diabetic coronary arteries
    • S.P. Marso, S.K. Mehta, and A. Frutkin Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in non-diabetic coronary arteries Diabetes Care 31 2008 989 994
    • (2008) Diabetes Care , vol.31 , pp. 989-994
    • Marso, S.P.1    Mehta, S.K.2    Frutkin, A.3
  • 28
    • 42249093693 scopus 로고    scopus 로고
    • The association between plasma adiponectin level and hypertension
    • A. Shankar, S. Marshall, and J. Li The association between plasma adiponectin level and hypertension Acta Cardiol 63 2008 160 165
    • (2008) Acta Cardiol , vol.63 , pp. 160-165
    • Shankar, A.1    Marshall, S.2    Li, J.3
  • 29
    • 0037231459 scopus 로고    scopus 로고
    • Osaka CAD Study Group: Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men
    • M. Kumada, S. Kihara, and S. Sumitsuji Osaka CAD Study Group: coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 85-89
    • Kumada, M.1    Kihara, S.2    Sumitsuji, S.3
  • 30
    • 84874824533 scopus 로고    scopus 로고
    • Serum levels of adiponectin and ghrelin in patients with acute myocardial infarction
    • E.O. Hamed, N.A. Zaky, and A.K. Norel Din Serum levels of adiponectin and ghrelin in patients with acute myocardial infarction Life Sci J 9 2012 523 526
    • (2012) Life Sci J , vol.9 , pp. 523-526
    • Hamed, E.O.1    Zaky, N.A.2    Norel Din, A.K.3
  • 31
    • 84870406340 scopus 로고    scopus 로고
    • Therapeutic perspectives for adiponectin: An update
    • F.Y.L. Li, K.S.L. Lam, and A. Xu Therapeutic perspectives for adiponectin: an update Curr Med Chem 19 2012 5513 5523
    • (2012) Curr Med Chem , vol.19 , pp. 5513-5523
    • Li, F.Y.L.1    Lam, K.S.L.2    Xu, A.3
  • 33
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3
  • 34
    • 77952708442 scopus 로고    scopus 로고
    • Effects of fibrates on cardiovascular outcomes: A systematic review and meta-analysis
    • M. Jun, C. Foote, and J. Lv Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis Lancet 375 2010 1875 1884
    • (2010) Lancet , vol.375 , pp. 1875-1884
    • Jun, M.1    Foote, C.2    Lv, J.3
  • 35
    • 70349342714 scopus 로고    scopus 로고
    • Effect of fibrates on lipid profiles and cardiovascular outcomes: A systematic review
    • S. Abourbih, K.B. Filion, and L. Joseph Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review Am J Med 122 2009 962
    • (2009) Am J Med , vol.122 , pp. 962
    • Abourbih, S.1    Filion, K.B.2    Joseph, L.3
  • 36
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
    • A. Keech, R.J. Simes, and P. Barter Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3
  • 37
    • 77951704587 scopus 로고    scopus 로고
    • Effects of combination lipid therapy in type 2 diabetes mellitus
    • ACCORD Study Group
    • ACCORD Study Group H.N. Ginsberg, M.B. Elam, and L.C. Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
    • (2010) N Engl J Med , vol.362 , pp. 1563-1574
    • Ginsberg, H.N.1    Elam, M.B.2    Lovato, L.C.3
  • 38
    • 0037319739 scopus 로고    scopus 로고
    • Statin effects beyond lipid lowering - Are they clinically relevant?
    • P.O. Bonetti, L.O. Lerman, and C. Napoli Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 24 2003 225 248
    • (2003) Eur Heart J , vol.24 , pp. 225-248
    • Bonetti, P.O.1    Lerman, L.O.2    Napoli, C.3
  • 41
    • 79956315187 scopus 로고    scopus 로고
    • Pleiotropic effects of statins: Evidence for benefits beyond LDL-cholesterol lowering
    • M. Marzilli Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering Am J Cardiovasc Drugs 10 2010 S3 S9
    • (2010) Am J Cardiovasc Drugs , vol.10
    • Marzilli, M.1
  • 42
  • 43
    • 84881642500 scopus 로고    scopus 로고
    • Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
    • A. Sahebkar, G.F. Watts, and D. Perrea Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials Atherosclerosis 230 2013 110 120
    • (2013) Atherosclerosis , vol.230 , pp. 110-120
    • Sahebkar, A.1    Watts, G.F.2    Perrea, D.3
  • 44
    • 18944381282 scopus 로고    scopus 로고
    • Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
    • K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia J Am Coll Cardiol 45 2005 1649 1653
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1649-1653
    • Koh, K.K.1    Quon, M.J.2    Han, S.H.3
  • 45
    • 34249731922 scopus 로고    scopus 로고
    • Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
    • C. Otto, B. Otto, and R.J. Frost Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia Acta Diabetol 44 2007 65 68
    • (2007) Acta Diabetol , vol.44 , pp. 65-68
    • Otto, C.1    Otto, B.2    Frost, R.J.3
  • 46
    • 34447322025 scopus 로고    scopus 로고
    • Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia
    • T. Nakamura, Y. Kodama, and H. Takano Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia Atherosclerosis 193 2007 449 451
    • (2007) Atherosclerosis , vol.193 , pp. 449-451
    • Nakamura, T.1    Kodama, Y.2    Takano, H.3
  • 47
    • 70350575193 scopus 로고    scopus 로고
    • Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment
    • M. Arca, V.M. Cambuli, and A. Montali Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment Nutr Metab Cardiovasc Dis 19 2009 660 666
    • (2009) Nutr Metab Cardiovasc Dis , vol.19 , pp. 660-666
    • Arca, M.1    Cambuli, V.M.2    Montali, A.3
  • 48
    • 79958821408 scopus 로고    scopus 로고
    • Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087
    • C.J. Fichtenbaum, T.M. Yeh, and S.R. Evans Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087 J Clin Lipidol 4 2010 279 287
    • (2010) J Clin Lipidol , vol.4 , pp. 279-287
    • Fichtenbaum, C.J.1    Yeh, T.M.2    Evans, S.R.3
  • 49
    • 84867908899 scopus 로고    scopus 로고
    • Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose
    • L. Buldak, A. Dulawa-Buldak, and K. Labuzek Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose Int J Clin Pharmacol Ther 50 2012 805 813
    • (2012) Int J Clin Pharmacol Ther , vol.50 , pp. 805-813
    • Buldak, L.1    Dulawa-Buldak, A.2    Labuzek, K.3
  • 50
    • 69449100622 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
    • (2009) BMJ , vol.339 , pp. 2535
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3
  • 52
    • 21544449115 scopus 로고    scopus 로고
    • Estimating the mean and variance from the median, range, and the size of a sample
    • S. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
    • (2005) BMC Med Res Methodol , vol.5 , pp. 13
    • Hozo, S.1    Djulbegovic, B.2    Hozo, I.3
  • 53
    • 84876135427 scopus 로고    scopus 로고
    • Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis
    • A. Sahebkar Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis DNA Cell Biol 32 2013 188 198
    • (2013) DNA Cell Biol , vol.32 , pp. 188-198
    • Sahebkar, A.1
  • 54
    • 0033934949 scopus 로고    scopus 로고
    • Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
    • S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
    • (2000) Biometrics , vol.56 , pp. 455-463
    • Duval, S.1    Tweedie, R.2
  • 56
    • 78651085122 scopus 로고    scopus 로고
    • Do statins beneficially or adversely affect glucose homeostasis?
    • M.S. Kostapanos, G.L. Liamis, and H.J. Milionis Do statins beneficially or adversely affect glucose homeostasis? Curr Vasc Pharmacol 8 2010 612 631
    • (2010) Curr Vasc Pharmacol , vol.8 , pp. 612-631
    • Kostapanos, M.S.1    Liamis, G.L.2    Milionis, H.J.3
  • 57
    • 67650702822 scopus 로고    scopus 로고
    • Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients
    • R. Sukhija, S. Prayaga, and M. Marashdeh Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients J Invest Med 57 2009 495 499
    • (2009) J Invest Med , vol.57 , pp. 495-499
    • Sukhija, R.1    Prayaga, S.2    Marashdeh, M.3
  • 58
    • 84869858921 scopus 로고    scopus 로고
    • Comparative study of the improvement effect of switching from fenofibrate to bezafibrate on lipid and glucose metabolism - Differences in effects between bezafibrate and fenofibrate in clinical practice
    • T. Goto, S. Yoshioka, and A. Suzuki Comparative study of the improvement effect of switching from fenofibrate to bezafibrate on lipid and glucose metabolism - differences in effects between bezafibrate and fenofibrate in clinical practice Ther Res 33 2012 1561 1568
    • (2012) Ther Res , vol.33 , pp. 1561-1568
    • Goto, T.1    Yoshioka, S.2    Suzuki, A.3
  • 59
    • 48749131386 scopus 로고    scopus 로고
    • Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients
    • H. Ando, K. Sugimoto, and H. Yanagihara Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients Clin Exp Pharmacol Physiol 35 2008 1012 1017
    • (2008) Clin Exp Pharmacol Physiol , vol.35 , pp. 1012-1017
    • Ando, H.1    Sugimoto, K.2    Yanagihara, H.3
  • 60
    • 34547887274 scopus 로고    scopus 로고
    • Efficacy of atorvastatin therapy in ischaemic heart disease - Effects on oxidized low-density lipoprotein and adiponectin
    • K. Miyagishima, S. Hiramitsu, and S. Kato Efficacy of atorvastatin therapy in ischaemic heart disease - effects on oxidized low-density lipoprotein and adiponectin J Int Med Res 35 2007 534 539
    • (2007) J Int Med Res , vol.35 , pp. 534-539
    • Miyagishima, K.1    Hiramitsu, S.2    Kato, S.3
  • 61
    • 43749111768 scopus 로고    scopus 로고
    • Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk
    • L.M. Blanco-Colio, J.L. Martin-Ventura, and C. Gomez-Guerrero Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk Eur J Pharmacol 586 2008 259 265
    • (2008) Eur J Pharmacol , vol.586 , pp. 259-265
    • Blanco-Colio, L.M.1    Martin-Ventura, J.L.2    Gomez-Guerrero, C.3
  • 62
    • 33748590264 scopus 로고    scopus 로고
    • The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: A pilot study
    • K. Sakamoto, T. Sakamoto, and H. Ogawa The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study Clin Ther 28 2006 1012 1021
    • (2006) Clin Ther , vol.28 , pp. 1012-1021
    • Sakamoto, K.1    Sakamoto, T.2    Ogawa, H.3
  • 63
    • 34548500220 scopus 로고    scopus 로고
    • Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
    • S. Sugiyama, H. Fukushima, and K. Kugiyama Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease Atherosclerosis 194 2007 e43 e51
    • (2007) Atherosclerosis , vol.194
    • Sugiyama, S.1    Fukushima, H.2    Kugiyama, K.3
  • 64
    • 79960988152 scopus 로고    scopus 로고
    • Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism
    • B. Cariou, Y. Zaïr, and B. Staels Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism Diabetes Care 34 2011 2008 2014
    • (2011) Diabetes Care , vol.34 , pp. 2008-2014
    • Cariou, B.1    Zaïr, Y.2    Staels, B.3
  • 65
    • 60849116123 scopus 로고    scopus 로고
    • Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients
    • R.S. Rosenson Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients Obesity (Silver Spring) 17 2009 504 509
    • (2009) Obesity (Silver Spring) , vol.17 , pp. 504-509
    • Rosenson, R.S.1
  • 66
    • 76149092815 scopus 로고    scopus 로고
    • Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome
    • R. Belfort, R. Berria, and J. Cornell Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome J Clin Endocrinol Metab 95 2010 829 836
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 829-836
    • Belfort, R.1    Berria, R.2    Cornell, J.3
  • 67
    • 79960239872 scopus 로고    scopus 로고
    • Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study
    • T. Noguchi, J. Kobayashi, and K. Yagi Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study Atherosclerosis 217 2011 165 170
    • (2011) Atherosclerosis , vol.217 , pp. 165-170
    • Noguchi, T.1    Kobayashi, J.2    Yagi, K.3
  • 68
    • 20844456215 scopus 로고    scopus 로고
    • Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients
    • K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients Circulation 110 2004 3687 3692
    • (2004) Circulation , vol.110 , pp. 3687-3692
    • Koh, K.K.1    Quon, M.J.2    Han, S.H.3
  • 69
    • 33947304608 scopus 로고    scopus 로고
    • Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in non-diabetic patients at cardiovascular risk - The PIOSTAT Study
    • T. Forst, A. Pfutzner, and G. Lubben Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in non-diabetic patients at cardiovascular risk - the PIOSTAT Study Metabolism 56 2007 491 496
    • (2007) Metabolism , vol.56 , pp. 491-496
    • Forst, T.1    Pfutzner, A.2    Lubben, G.3
  • 70
    • 48649083592 scopus 로고    scopus 로고
    • Simvastatin improves flowmediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients
    • K.K. Koh, M.J. Quon, and S.H. Han Simvastatin improves flowmediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients Diabetes Care 31 2008 776 782
    • (2008) Diabetes Care , vol.31 , pp. 776-782
    • Koh, K.K.1    Quon, M.J.2    Han, S.H.3
  • 71
    • 35348874956 scopus 로고    scopus 로고
    • Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome
    • S. Devaraj, D. Siegel, and I. Jialal Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome Am J Cardiol 100 2007 1397 1399
    • (2007) Am J Cardiol , vol.100 , pp. 1397-1399
    • Devaraj, S.1    Siegel, D.2    Jialal, I.3
  • 72
    • 69349102944 scopus 로고    scopus 로고
    • Antiatherosclerotic and anti-insulin resistance effects of adiponectin: Basic and clinical studies
    • S.H. Han, I. Sakuma, and E.K. Shin Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies Prog Cardiovasc Dis 52 2009 126 140
    • (2009) Prog Cardiovasc Dis , vol.52 , pp. 126-140
    • Han, S.H.1    Sakuma, I.2    Shin, E.K.3
  • 73
    • 0242581695 scopus 로고    scopus 로고
    • Adiponectin stimulates production of nitric oxide in vascular endothelial cells
    • H. Chen, M. Montagnani, and T. Funahashi Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
    • (2003) J Biol Chem , vol.278 , pp. 45021-45026
    • Chen, H.1    Montagnani, M.2    Funahashi, T.3
  • 74
    • 10744223954 scopus 로고    scopus 로고
    • Association of hypoadiponectinemia with impaired vasoreactivity
    • N. Ouchi, M. Ohishi, and S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
    • (2003) Hypertension , vol.42 , pp. 231-234
    • Ouchi, N.1    Ohishi, M.2    Kihara, S.3
  • 75
    • 0037129861 scopus 로고    scopus 로고
    • Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
    • Y. Arita, S. Kihara, and N. Ouchi Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
    • (2002) Circulation , vol.105 , pp. 2893-2898
    • Arita, Y.1    Kihara, S.2    Ouchi, N.3
  • 76
    • 24044538551 scopus 로고    scopus 로고
    • Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
    • Y. Wang, K.S. Lam, and J.Y. Xu Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner J Biol Chem 280 2005 18341 18347
    • (2005) J Biol Chem , vol.280 , pp. 18341-18347
    • Wang, Y.1    Lam, K.S.2    Xu, J.Y.3
  • 77
    • 0034641647 scopus 로고    scopus 로고
    • Adiponectin, adipocyte-derived protein, inhibits endothelial NFkB signaling through cAMP-dependent pathway
    • N. Ouchi, S. Kihara, and Y. Arita Adiponectin, adipocyte-derived protein, inhibits endothelial NFkB signaling through cAMP-dependent pathway Circulation 102 2000 1296 1301
    • (2000) Circulation , vol.102 , pp. 1296-1301
    • Ouchi, N.1    Kihara, S.2    Arita, Y.3
  • 78
    • 0033613545 scopus 로고    scopus 로고
    • Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein
    • N. Ouchi, S. Kihara, and Y. Arita Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein Circulation 100 1999 2473 2476
    • (1999) Circulation , vol.100 , pp. 2473-2476
    • Ouchi, N.1    Kihara, S.2    Arita, Y.3
  • 79
    • 34249720420 scopus 로고    scopus 로고
    • Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver
    • F. Matsuura, H. Oku, and M. Koseki Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver Biochem Biophys Res Commun 358 2007 1091 1095
    • (2007) Biochem Biophys Res Commun , vol.358 , pp. 1091-1095
    • Matsuura, F.1    Oku, H.2    Koseki, M.3
  • 80
    • 50849100403 scopus 로고    scopus 로고
    • Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
    • K. Tsubakio-Yamamoto, F. Matsuura, and M. Koseki Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages Biochem Biophys Res Commun 375 2008 390 394
    • (2008) Biochem Biophys Res Commun , vol.375 , pp. 390-394
    • Tsubakio-Yamamoto, K.1    Matsuura, F.2    Koseki, M.3
  • 81
    • 46249092855 scopus 로고    scopus 로고
    • Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells; Evidence for an adipose tissue-vascular loop
    • S. Devaraj, N. Torok, and R. Mohan Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells; evidence for an adipose tissue-vascular loop Arterioscler Thromb Vasc Biol 28 2008 1368 1374
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 1368-1374
    • Devaraj, S.1    Torok, N.2    Mohan, R.3
  • 82
    • 0035957040 scopus 로고    scopus 로고
    • Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
    • N. Ouchi, S. Kihara, and Y. Arita Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
    • (2001) Circulation , vol.103 , pp. 1057-1063
    • Ouchi, N.1    Kihara, S.2    Arita, Y.3
  • 83
    • 50949114724 scopus 로고    scopus 로고
    • Reversal of oxidative stress in endothelial cells by controlled release of adiponectin
    • M. Mossalam, J.H. Jeong, and E.D. Abel Reversal of oxidative stress in endothelial cells by controlled release of adiponectin J Control Release 130 2008 234 237
    • (2008) J Control Release , vol.130 , pp. 234-237
    • Mossalam, M.1    Jeong, J.H.2    Abel, E.D.3
  • 84
    • 19444375353 scopus 로고    scopus 로고
    • Effects of adipocyte-derived cytokines on endothelial functions: Implication of vascular disease
    • P. Kougias, H. Chai, and P.H. Lin Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease J Surg Res 126 2005 121 129
    • (2005) J Surg Res , vol.126 , pp. 121-129
    • Kougias, P.1    Chai, H.2    Lin, P.H.3
  • 86
    • 77951709095 scopus 로고    scopus 로고
    • Pleiotropic effects of statins. Basic research and clinical perspectives
    • Q. Zhou, and J.K. Liao Pleiotropic effects of statins. Basic research and clinical perspectives Circ J 74 2010 818 826
    • (2010) Circ J , vol.74 , pp. 818-826
    • Zhou, Q.1    Liao, J.K.2
  • 87
    • 64749110885 scopus 로고    scopus 로고
    • Pleiotropic effects of statins - Clinical evidence
    • V.G. Athyros, A.I. Kakafika, and K. Tziomalos Pleiotropic effects of statins - clinical evidence Curr Pharm Des 15 2009 479 489
    • (2009) Curr Pharm des , vol.15 , pp. 479-489
    • Athyros, V.G.1    Kakafika, A.I.2    Tziomalos, K.3
  • 88
    • 10644259543 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial
    • P.S. Sever, B. Dahlof, and N.R. Poulter Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Drugs 64 2004 S43 S60
    • (2004) Drugs , vol.64
    • Sever, P.S.1    Dahlof, B.2    Poulter, N.R.3
  • 89
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Simvastatin Survival Study Group
    • Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 90
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators
    • F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators N Engl J Med 335 1996 1001 1009
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 91
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 1998 1349 1357
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 92
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 93
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 94
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
    • J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 95
    • 79956370935 scopus 로고    scopus 로고
    • Pleiotropic effects of statins: Evidence against benefits beyond LDL-cholesterol lowering
    • T.R. Pedersen Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering Am J Cardiovasc Drugs 10 2010 S10 S17
    • (2010) Am J Cardiovasc Drugs , vol.10
    • Pedersen, T.R.1
  • 96
    • 80052048877 scopus 로고    scopus 로고
    • Non-invited review: Prevention of microvascular diabetic complications by fenofibrate: Lessons from FIELD and ACCORD
    • M.P. Hermans Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD Diab Vasc Dis Res 8 2011 180 189
    • (2011) Diab Vasc Dis Res , vol.8 , pp. 180-189
    • Hermans, M.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.